| RS1559585778 |
BAP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS1559586168 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, BAP1-related tumor predisposition syndrome |
| RS1559586374 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1559586695 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS1559586782 |
BAP1
|
Health Risk |
Likely pathogenic |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1559586965 |
BAP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1559587104 |
BAP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS1559587112 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1559587902 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS1559587957 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS1559588330 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1559588540 |
MLH1
|
Health Risk |
Likely pathogenic |
Colorectal cancer, hereditary nonpolyposis |
| RS1559588632 |
BAP1
|
Health Risk |
Pathogenic |
Uveal melanoma, Uveal melanoma |
| RS1559588683 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS1559589139 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1559589252 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1559589344 |
BAP1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1559589809 |
BAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1559590037 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS1559590603 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS1559590613 |
BAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS1559590789 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS1559590832 |
TMEM237
|
Health Risk |
Pathogenic |
— |
| RS1559591264 |
BAP1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neoplasm |
| RS1559591314 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS1559591511 |
BAP1
|
Health Risk |
Likely pathogenic |
BAP1-related tumor predisposition syndrome, BAP1-related tumor predisposition syndrome |
| RS1559591546 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Lynch syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1559591695 |
CTLA4
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency, Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency |
| RS1559591728 |
BAP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1559592415 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1559592875 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS1559592900 |
BTD
|
Health Risk |
Likely pathogenic |
Biotinidase deficiency, Biotinidase deficiency |
| RS1559593101 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1559593177 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS1559593339 |
BAP1
|
Health Risk |
Likely pathogenic |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1559593389 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, BAP1-related tumor predisposition syndrome |
| RS1559594442 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal dominant Alport syndrome, Autosomal recessive Alport syndrome |
| RS1559595807 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1559595840 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Colorectal cancer |
| RS1559596230 |
FOXP1
|
Health Risk |
Likely pathogenic |
— |
| RS1559596699 |
FOXP1
|
Health Risk |
Likely pathogenic |
— |
| RS1559596756 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS1559597322 |
MLH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1559597540 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome |
| RS1559598775 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1559599859 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1559600608 |
BTD
|
Health Risk |
Conflicting classifications of pathogenicity |
Biotinidase deficiency, Biotinidase deficiency |
| RS1559600871 |
BTD
|
Health Risk |
Pathogenic/Likely pathogenic |
Biotinidase deficiency, Biotinidase deficiency |
| RS1559600938 |
BTD
|
Health Risk |
Pathogenic/Likely pathogenic |
Biotinidase deficiency, Biotinidase deficiency |
| RS1559601041 |
BTD
|
Health Risk |
Likely pathogenic |
Biotinidase deficiency, Biotinidase deficiency |
| RS1559602356 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability |
| RS1559602593 |
FOXP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS1559602980 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1559603328 |
ITPR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Spinocerebellar ataxia type 29, Spinocerebellar ataxia type 15/16 |
| RS1559603629 |
ITPR1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1559604072 |
FN1
|
Health Risk |
Pathogenic |
Spondylometaphyseal dysplasia, Spondylometaphyseal dysplasia |
| RS1559604548 |
EOGT
|
Health Risk |
Likely pathogenic |
Adams-Oliver syndrome 4, Adams-Oliver syndrome 4 |
| RS1559606445 |
COL4A4
|
Health Risk |
Pathogenic |
Autosomal dominant Alport syndrome, Alport syndrome |
| RS1559609410 |
FN1
|
Health Risk |
Likely pathogenic |
Spondylometaphyseal dysplasia, Spondylometaphyseal dysplasia |
| RS1559614110 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1559614642 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1559614730 |
POU1F1
|
Health Risk |
Likely pathogenic |
Pituitary hormone deficiency, combined |
| RS1559616744 |
FN1
|
Health Risk |
Likely pathogenic |
Spondylometaphyseal dysplasia, Spondylometaphyseal dysplasia |
| RS1559616778 |
FOXP1
|
Health Risk |
Pathogenic |
— |
| RS1559617016 |
FOXP1
|
Health Risk |
Likely pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS1559617617 |
COL4A4
|
Health Risk |
Likely pathogenic |
Alport syndrome, Alport syndrome |
| RS1559619762 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability, Autism |
| RS1559620132 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal dominant Alport syndrome, Autosomal dominant Alport syndrome |
| RS1559620376 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS1559621862 |
FOXP1
|
Health Risk |
Likely pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Squamous cell lung carcinoma |
| RS1559622431 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1559622516 |
SLC6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Epilepsy with myoclonic atonic seizures, SLC6A1-related disorder |
| RS1559623389 |
SLC6A1
|
Health Risk |
Likely pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS1559626646 |
SLC6A1
|
Health Risk |
Likely pathogenic |
— |
| RS1559628183 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal dominant Alport syndrome, Autosomal dominant Alport syndrome |
| RS1559629701 |
SLC6A1
|
Health Risk |
Pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS1559629912 |
PRKCD
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome, type III caused by mutation in PRKCD |
| RS1559630167 |
SLC6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Epilepsy with myoclonic atonic seizures |
| RS1559631986 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Hematuria |
| RS1559633512 |
SLC6A1
|
Health Risk |
Likely pathogenic |
— |
| RS1559634490 |
SETD2
|
Health Risk |
Pathogenic |
— |
| RS1559637815 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease, type IV |
| RS1559638068 |
ITPR1
|
Health Risk |
Pathogenic |
Gillespie syndrome, Gillespie syndrome |
| RS1559639240 |
SLC6A1
|
Health Risk |
Likely pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS1559640454 |
SLC6A1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1559642470 |
IMPG2
|
Health Risk |
Likely pathogenic |
Vitelliform macular dystrophy 5, Vitelliform macular dystrophy 5 |
| RS1559643320 |
IMPG2
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1559643753 |
COL4A4
|
Health Risk |
Likely pathogenic |
Benign familial hematuria, Benign familial hematuria |
| RS1559644463 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal dominant Alport syndrome, Autosomal dominant Alport syndrome |
| RS1559646395 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal dominant Alport syndrome, Benign familial hematuria |
| RS1559650552 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS1559654264 |
CAV3
|
Health Risk |
Likely pathogenic |
Rippling muscle disease 2, Rippling muscle disease 2 |
| RS1559655653 |
ACVR2B
|
Health Risk |
Likely pathogenic |
Heterotaxy, visceral |
| RS1559662068 |
BRPF1
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with dysmorphic facies and ptosis, Intellectual developmental disorder with dysmorphic facies and ptosis |
| RS1559662077 |
BRPF1
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with dysmorphic facies and ptosis, Intellectual developmental disorder with dysmorphic facies and ptosis |
| RS1559663225 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1559669161 |
TTN
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS1559669986 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1559671858 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1559673456 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease IV, classic hepatic |